HILLARY WINKLER: Open Payments
NPI 1205601440 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,728 in 100 payments from 21 companies in 2025. Trend: 2023 $16 · 2024 $1,514 · 2025 $2,728
Food & beverage: $2,628Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $493 |
| GENZYME CORPORATION | 9 | $285 |
| Incyte Corporation | 7 | $275 |
| ABBVIE INC. | 11 | $215 |
| Regeneron Healthcare Solutions, Inc. | 7 | $191 |
| Novartis Pharmaceuticals Corporation | 9 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $151 |
| Organogenesis Inc. | 4 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $130 |
| Amgen Inc. | 6 | $118 |
Products named: TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, COSENTYX, SPEVIGO, Otezla, Leqselvi.
Industry payments across MD — which companies pay providers there.
